Workforce health index flags rising stress and blood sugar

Rising stress, elevated blood sugar and persistent vitamin gaps are the headline findings of the India Workforce Health Index 2026, a new report on the health of India's urban working population. Published by Loop Health, the second edition of the index analysed 816,003 biomarker results from 11,427 laboratory reports, along with 9,097 survey responses and 74,339 hospital insurance claims. The findings describe patterns in those datasets, not the health of one group of workers followed over time, since the laboratory, survey and claims data were not linked to the same people.

In the workforce health survey, high stress, rated at 7 or more out of 10, rose from 33.9 percent in 2025 to 40.4 percent in 2026, a rise of 6.5 percentage points. The average stress rating rose from 5.01 to 5.56. Women reported high stress more often than men, with the share rising from 41.2 percent to 47.4 percent among women and from 30.5 percent to 37.3 percent among men. By working arrangement, high stress was reported by 42.4 percent of home-based workers, 40.5 percent of office-based workers and 38.5 percent of hybrid workers, and employee stress was highest among home-based workers.

Workforce health and blood sugar in the 2026 data

Blood sugar was the most widespread metabolic finding in the workforce health data. Overall, 38.7 percent of HbA1c reports were at or above 5.7 percent, the report's threshold for elevated levels, including 25.4 percent in the 5.7 to 6.4 percent range and 13.3 percent at 6.5 percent or above. HbA1c reflects average glucose over roughly the previous three months, with 5.7 percent marking the start of the prediabetes range and 6.5 percent the threshold used for diabetes. A diabetes-range result generally needs confirmation with repeat testing or another diagnostic test.

For workforce health, age made a larger difference than the year-to-year change. Elevated levels appeared in 16.7 percent of reports from people in their 20s, 33.0 percent in their 30s, 52.9 percent in their 40s and 69.1 percent in their 50s. One in three professionals in their 30s showed glucose dysfunction, the report's co-founder and chief operating officer Ryan Singh said, calling the early appearance of risks the most important finding. The report also measured glucose dysfunction at 31.3 percent among employees tested in 2026, a separate measure from the HbA1c share.

Workforce health: sleep, vitamins and city differences

Sleep fell back in the workforce health survey, with the share reporting seven or more hours of sleep dropping from 37.0 percent in 2025 to 30.7 percent in 2026. The share reporting no day with at least 30 minutes of exercise rose from 28.0 percent to 30.9 percent, while regular exercise on three or more days a week was almost unchanged at 37.2 percent against 37.9 percent. Short sleep affected about one in four respondents who reported no workday caffeine drinks, against more than four in 10 among those reporting four or more drinks a day, though the report notes this is an association, not proof that caffeine caused shorter sleep.

Vitamin gaps stayed wide in the workforce health data. Nearly seven in 10 vitamin B12 reports were below 300 pg/mL, against 68.2 percent in 2025, and 34.5 percent were below 200 pg/mL. Vitamin D below 20 ng/mL fell from 65.9 percent to 60.1 percent, and severe deficiency below 10 ng/mL fell from 28.0 percent to 22.2 percent. Among five metros studied, Mumbai had the highest share of elevated HbA1c at 46.8 percent, Bengaluru had the highest share of low vitamin B12 at 78.8 percent, and Pune recorded 43.2 percent elevated HbA1c, up from 30.2 percent in the previous edition.

The Workforce Health Index 2026 also covered how workers seek health information and what they know about newer medicines, rounding out the workforce health picture. Just over half of respondents, 54 percent, said they consulted doctors or healthcare professionals, while 19.8 percent reported using AI tools and 19.7 percent relied on Google. More than half of respondents, 54.4 percent, said they had never heard of GLP-1 medicines such as Ozempic, Wegovy or Mounjaro, while 26.1 percent reported some awareness. The laboratory findings came from insured employees and covered family members who underwent testing, rather than a nationally representative sample of India's whole workforce, and employee stress remained the clearest year-to-year change.